Q3 2019 Neurocrine Biosciences Inc Earnings Call Transcript
Good day, everyone, and welcome to the Neurocrine Biosciences Third Quarter 2019 Results Call. (Operator Instructions) Today's program is being recorded, and I will be standing by if you should need any assistance. It is now my pleasure to turn today's conference over to the CEO of Neurocrine Biosciences, Kevin Gorman.
Thank you, and welcome, everyone, to our earnings call. I'm joined today by Matt Abernethy, our Chief Financial Officer; Eiry Roberts, our Chief Medical Officer; Eric Benevich, our Chief Commercial Officer; Kyle Gano, our Chief Business Development and Strategy Officer; and
(technical difficulty)
of Investor Relations.
Before we begin, I'd like to ask Todd to read our safe harbor statement.
Yes. So good afternoon, everyone. Certain statements made in the course of this conference call that are not historical statements may be forward-looking statements,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |